UniProt ID | ELP4_HUMAN | |
---|---|---|
UniProt AC | Q96EB1 | |
Protein Name | Elongator complex protein 4 | |
Gene Name | ELP4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 424 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Acts as subunit of the RNA polymerase II elongator complex, which is a histone acetyltransferase component of the RNA polymerase II (Pol II) holoenzyme and is involved in transcriptional elongation. Elongator may play a role in chromatin remodeling and is involved in acetylation of histones H3 and probably H4.. | |
Protein Sequence | MAAVATCGSVAASTGSAVATASKSNVTSFQRRGPRASVTNDSGPRLVSIAGTRPSVRNGQLLVSTGLPALDQLLGGGLAVGTVLLIEEDKYNIYSPLLFKYFLAEGIVNGHTLLVASAKEDPANILQELPAPLLDDKCKKEFDEDVYNHKTPESNIKMKIAWRYQLLPKMEIGPVSSSRFGHYYDASKRMPQELIEASNWHGFFLPEKISSTLKVEPCSLTPGYTKLLQFIQNIIYEEGFDGSNPQKKQRNILRIGIQNLGSPLWGDDICCAENGGNSHSLTKFLYVLRGLLRTSLSACIITMPTHLIQNKAIIARVTTLSDVVVGLESFIGSERETNPLYKDYHGLIHIRQIPRLNNLICDESDVKDLAFKLKRKLFTIERLHLPPDLSDTVSRSSKMDLAESAKRLGPGCGMMAGGKKHLDF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | O-linked_Glycosylation | --MAAVATCGSVAAS --CCCEEECCHHHHH | 15.71 | 30379171 | |
6 | Phosphorylation | --MAAVATCGSVAAS --CCCEEECCHHHHH | 15.71 | 23532336 | |
9 | O-linked_Glycosylation | AAVATCGSVAASTGS CCEEECCHHHHHCCC | 15.66 | 30379171 | |
9 | Phosphorylation | AAVATCGSVAASTGS CCEEECCHHHHHCCC | 15.66 | 23401153 | |
20 | Phosphorylation | STGSAVATASKSNVT HCCCHHHHCCCCCCC | 25.51 | 23532336 | |
22 | Phosphorylation | GSAVATASKSNVTSF CCHHHHCCCCCCCCC | 32.06 | 23532336 | |
24 | Phosphorylation | AVATASKSNVTSFQR HHHHCCCCCCCCCCC | 33.75 | 26434776 | |
27 | Phosphorylation | TASKSNVTSFQRRGP HCCCCCCCCCCCCCC | 28.24 | 26434776 | |
28 | Phosphorylation | ASKSNVTSFQRRGPR CCCCCCCCCCCCCCC | 18.33 | 28857561 | |
37 | Phosphorylation | QRRGPRASVTNDSGP CCCCCCCEECCCCCC | 30.65 | 21955146 | |
39 | Phosphorylation | RGPRASVTNDSGPRL CCCCCEECCCCCCCE | 30.71 | 25137130 | |
42 | Phosphorylation | RASVTNDSGPRLVSI CCEECCCCCCCEEEE | 53.41 | 25137130 | |
52 | Phosphorylation | RLVSIAGTRPSVRNG CEEEECCCCCCCCCC | 30.31 | 28857561 | |
55 | Phosphorylation | SIAGTRPSVRNGQLL EECCCCCCCCCCEEE | 30.34 | 28857561 | |
137 | Ubiquitination | PAPLLDDKCKKEFDE CCCCCCHHHHHHCCH | 47.85 | - | |
140 | Ubiquitination | LLDDKCKKEFDEDVY CCCHHHHHHCCHHHH | 73.43 | - | |
147 | Phosphorylation | KEFDEDVYNHKTPES HHCCHHHHCCCCCCH | 24.70 | 25159151 | |
150 | Ubiquitination | DEDVYNHKTPESNIK CHHHHCCCCCCHHCC | 63.24 | - | |
151 | Phosphorylation | EDVYNHKTPESNIKM HHHHCCCCCCHHCCC | 25.41 | 25159151 | |
154 | Phosphorylation | YNHKTPESNIKMKIA HCCCCCCHHCCCEEE | 45.09 | 25159151 | |
164 | Phosphorylation | KMKIAWRYQLLPKME CCEEEEEEECCCCCE | 7.88 | 23898821 | |
176 | Phosphorylation | KMEIGPVSSSRFGHY CCEECCCCHHHCCCC | 26.23 | 23898821 | |
177 | Phosphorylation | MEIGPVSSSRFGHYY CEECCCCHHHCCCCC | 26.26 | 23898821 | |
183 | Phosphorylation | SSSRFGHYYDASKRM CHHHCCCCCCHHHCC | 11.92 | 27461979 | |
184 | Phosphorylation | SSRFGHYYDASKRMP HHHCCCCCCHHHCCC | 10.20 | 27461979 | |
187 | Phosphorylation | FGHYYDASKRMPQEL CCCCCCHHHCCCHHH | 20.21 | 27461979 | |
188 | Ubiquitination | GHYYDASKRMPQELI CCCCCHHHCCCHHHH | 55.20 | - | |
189 | Ubiquitination | HYYDASKRMPQELIE CCCCHHHCCCHHHHH | 39.25 | - | |
198 | Phosphorylation | PQELIEASNWHGFFL CHHHHHHHCCCCCCC | 27.88 | 27461979 | |
214 | Ubiquitination | EKISSTLKVEPCSLT HHHCCCEEEEECCCC | 44.64 | - | |
215 | Ubiquitination | KISSTLKVEPCSLTP HHCCCEEEEECCCCC | 12.80 | - | |
295 | Phosphorylation | LRGLLRTSLSACIIT HHHHHHHHHHHHHHC | 17.56 | 22210691 | |
302 | Phosphorylation | SLSACIITMPTHLIQ HHHHHHHCCCHHHHC | 9.37 | 22210691 | |
341 | Phosphorylation | ERETNPLYKDYHGLI CCCCCCCCCCCCCEE | 11.76 | 26657352 | |
367 | Ubiquitination | ICDESDVKDLAFKLK CCCHHHHHHHHHHHH | 52.60 | - | |
368 | Ubiquitination | CDESDVKDLAFKLKR CCHHHHHHHHHHHHH | 42.98 | - | |
376 | Ubiquitination | LAFKLKRKLFTIERL HHHHHHHHHHEEEEC | 46.49 | - | |
379 | Phosphorylation | KLKRKLFTIERLHLP HHHHHHHEEEECCCC | 32.15 | 28857561 | |
390 | Phosphorylation | LHLPPDLSDTVSRSS CCCCCCCHHHCCHHH | 38.32 | 28555341 | |
392 | Phosphorylation | LPPDLSDTVSRSSKM CCCCCHHHCCHHHHH | 19.60 | 28555341 | |
404 | Phosphorylation | SKMDLAESAKRLGPG HHHHHHHHHHHHCCC | 33.22 | 21857030 | |
406 | Ubiquitination | MDLAESAKRLGPGCG HHHHHHHHHHCCCCC | 58.39 | - | |
419 | Acetylation | CGMMAGGKKHLDF-- CCCCCCCCCCCCC-- | 35.78 | 25953088 | |
419 | Methylation | CGMMAGGKKHLDF-- CCCCCCCCCCCCC-- | 35.78 | - | |
420 | Methylation | GMMAGGKKHLDF--- CCCCCCCCCCCC--- | 53.31 | - | |
499 (in isoform 2) | Phosphorylation | - | 25690035 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ELP4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ELP4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ELP4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRP68_HUMAN | SRP68 | physical | 22863883 | |
ELP2_HUMAN | ELP2 | physical | 26344197 | |
SF3B3_HUMAN | SF3B3 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-42, AND MASSSPECTROMETRY. |